Effects of ACE inhibitors, calcium antagonists, and other blood-pressure-lowering drugs: results of prospectively designed overviews of randomised trials. Blood Pressure Lowering Treatment Trialists' Collaboration.
about
Interventions used to improve control of blood pressure in patients with hypertensionWalking for hypertensionHypolipidemic and antihypertensive drugs for prevention of cardiovascular complications in patients with rheumatoid arthritisTreatment of hypertension in the UK: simple as ABCD?Use of blood pressure lowering drugs in the prevention of cardiovascular disease: meta-analysis of 147 randomised trials in the context of expectations from prospective epidemiological studiesLercanidipine is an effective and well tolerated antihypertensive drug regardless the cardiovascular risk profile: The LAURA studyDebate: does it matter how you lower blood pressure?Benefits and side effects of blood pressure lowering treatment: what was wrong with doxazosin in the ALLHAT?The potential savings of using thiazides as the first choice antihypertensive drug: cost-minimisation analysisA novel approach to treatment of hypertension in diabetic patients - a multicenter, double-blind, randomized study comparing the efficacy of combination therapy of Eprosartan versus Ramipril with low-dose Hydrochlorothiazide and Moxonidine on bloodDiuretics: again the first step in the treatment of most patients with hypertensionStabilization of high-risk plaquesCardiovascular drugs in the treatment of infantile hemangiomaA Randomized Trial of Intensive versus Standard Blood-Pressure ControlPURLs: "Go low" or say "No" to aggressive systolic BP goals?Coronary heart disease prevention: insights from modelling incremental cost effectivenessBritish Hypertension Society guidelines for hypertension management 2004 (BHS-IV): summaryQueen Mary Utilization of Antihypertensive Drugs Study: use of antihypertensive drug classes in the hypertension clinic 1996-2004A cure for cardiovascular disease? Combination treatment has enormous potential, especially in developing countriesStroke prevention in diabetes and obesityPrimary prevention of cardiovascular disease: cost-effectiveness comparisonA new paradigm of cardiovascular risk factor modificationCost-effectiveness of medical interventions to prevent cardiovascular disease in a sub-Saharan African country--the case of TanzaniaMultivariate risk assessment and risk score cards in hypertensionPharmacological effects of AVE 0991, a nonpeptide angiotensin-(1-7) receptor agonistA novel method to adjust efficacy estimates for uptake of other active treatments in long-term clinical trialsCost-effectiveness of a hypertension management programme in an elderly population: a Markov model.Primary prevention of cardiovascular diseases: a cost study in family practices.Frequency of cardiovascular events in patients treated with anti hypertensive agents: A cohort study based on claims data generated by primary care practice.Use of Pharmacy Sales Data to Assess Changes in Prescription- and Payment-Related Factors that Promote Adherence to Medications Commonly Used to Treat Hypertension, 2009 and 2014.Methods underpinning national clinical guidelines for hypertension: describing the evidence shortfall.Costs of hospital care for hypertension in an insured population without an outpatient medicines benefit: an observational study in the Philippines.Literacy and blood pressure--do healthcare systems influence this relationship? A cross-sectional study.Effect of lowering blood pressure on cardiovascular events and mortality in patients on dialysis: a systematic review and meta-analysis of randomised controlled trialsIs primary care a neglected piece of the jigsaw in ensuring optimal stroke care? Results of a national study.The features of reserpine-induced gastric mucosal lesionsAntihypertensive medications: benefits of blood pressure lowering and hazards of metabolic effects.ALLHAT findings revisited in the context of subsequent analyses, other trials, and meta-analysesRelaxation of rat aorta by farrerol correlates with potency to reduce intracellular calcium of VSMCsMyocardial infarction and stroke associated with diuretic based two drug antihypertensive regimens: population based case-control study.
P2860
Q24236536-31A8378F-A89A-479D-86BF-9BE0EE4BBA53Q24236765-90C9709E-9CB1-4839-A733-EFA27F048FB8Q24242787-F74D67FD-EA13-4193-9238-268C4482557FQ24558616-E945E003-E2DD-4C32-919D-C6718C8D38C3Q24658205-3B53DD78-CB7A-454C-976E-F55779F96EC8Q24672576-306BCF57-EEC6-4039-B692-E5DADB0C57B8Q24792999-F668C79C-487E-4B9C-BCA8-51925FB8CD11Q24799267-AC3C0CC8-E971-475B-B59D-FF123FF1A44BQ24801524-F013F332-FC32-4AB8-A026-6F393BB2C859Q24806038-CA24AA09-CAD9-4F63-A5B8-86A6D1DF7EF7Q24806951-DA09F249-27B3-47A3-9D5B-36DF698BA23CQ26738584-682623BE-32FC-471E-9866-A2F65FE8A6B4Q26769978-11E5395C-0A15-40C7-A43C-BD81AE7595D3Q27231406-5DF91088-0C34-4E05-BE69-5A0790BAA9A8Q28078922-56CF9E6F-6FDA-45CA-A90A-2D6994EF5B08Q28166294-A2CB482A-F98A-43C1-B40F-EF40AB36A1C7Q28167733-93F2E439-7A5B-4705-8183-1810DF1A0651Q28180976-5ED66E3F-F13E-4D35-94EF-B6F81C9CB842Q28196568-8AD1D9CF-CD31-45FF-8870-603DA44742ABQ28200179-AAB3A00D-9E8E-4498-8A09-9706004DAF45Q28217877-D7B60D73-9846-45D0-BB00-15D048EAF70BQ28219234-ACC4937D-1865-4834-BF77-26031088705BQ28219296-4BF56C51-245E-4DAE-9A8A-6C6229AA188BQ28219606-9F03FB95-6368-4E7F-87B6-7A8D1A5D172CQ28282619-D7227B30-1D78-4E9E-8695-771EB2E89AA2Q28472432-91780D65-1138-4A57-90EE-D4E2F23789E8Q30499940-D83B9CA9-C047-4CC3-BC35-9F084F9C2877Q30503671-A5704683-9200-49CA-8DB4-6D62F107A792Q30808567-32C7C70C-F07F-4898-90BB-A902CC1414AAQ31115388-B72950E4-D9A3-4382-80A9-786E23340AF6Q33239013-70F74EBB-2133-4359-AAD4-D4B2F07DDD0BQ33355842-57E5C591-273A-4C16-9BE1-A3D2D4ED5E3FQ33378978-64F87038-5CC6-483F-90A1-22B617E9EB88Q33413288-A25FAF19-6AC0-4A4D-8866-13194BFA49F4Q33436451-31780A0D-95AF-4E2C-9C07-78FE6ED653EFQ33557881-F674B7CB-411C-4767-9BB8-597535B3A44EQ33561456-BA3CDC5A-2058-4694-B6BA-F7CB9B8D625DQ33576830-B3D263B8-77FD-4222-984D-56A30F8B58D3Q33580740-EB4BEC80-F9FF-4E53-AA6F-99DE53B29BBAQ33609742-A1B8E71A-8BE5-4BD2-B904-7F333724E5A0
P2860
Effects of ACE inhibitors, calcium antagonists, and other blood-pressure-lowering drugs: results of prospectively designed overviews of randomised trials. Blood Pressure Lowering Treatment Trialists' Collaboration.
description
2000 nî lūn-bûn
@nan
2000 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Effects of ACE inhibitors, cal ...... ment Trialists' Collaboration.
@ast
Effects of ACE inhibitors, cal ...... ment Trialists' Collaboration.
@en
type
label
Effects of ACE inhibitors, cal ...... ment Trialists' Collaboration.
@ast
Effects of ACE inhibitors, cal ...... ment Trialists' Collaboration.
@en
prefLabel
Effects of ACE inhibitors, cal ...... ment Trialists' Collaboration.
@ast
Effects of ACE inhibitors, cal ...... ment Trialists' Collaboration.
@en
P2093
P1433
P1476
Effects of ACE inhibitors, cal ...... ment Trialists' Collaboration.
@en
P2093
Blood Pressure Lowering Treatment Trialists' Collaboration
S MacMahon
P304
P356
10.1016/S0140-6736(00)03307-9
P407
P577
2000-12-01T00:00:00Z